Bio-start Confirms Sir Richard Sykes as Chair of Judging Panel
- Posted on 5 October, 2016
SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial College Healthcare and Chancellor of Brunel University, will act as Chair of judges for the Bio-start competition judging panel in 2017.
Bio-start, a new annual competition founded by SynbiCITE and Rainbow Seed Fund, aims to incentivize innovative early-stage companies and people with great engineering biology ideas. Winners of this not-for-profit competition will receive a £100k cash prize, along with laboratory space, a ten-week accelerator programme with mentorship, consumables and professional services valued at ~£100k.
Sir Richard Sykes brings to the judging panel over 30 years’ experience in the biotechnology and pharmaceutical industries. During a distinguished career, Sir Richard has held many influential and senior roles in the UK and abroad including being Chairman of NHS London, Rector of Imperial College London, Senior Independent Director of Rio Tinto plc, Chief Executive and Chairman of GlaxoWellcome and later GlaxoSmithkline.
“Synthetic Biology is a key high-growth emerging technology in the UK, and I look forward helping select a future early-stage synthetic biology innovator,” commented Sir Richard.
Competition participants are encouraged to register on the Bio-start website by 14 October 2016. Application areas can be in healthcare, clean tech, industrial biotech or any sector that makes use of synthetic biology. Selection of the winning entry will take place at the final award ceremony Spring 2017. Full competition details can be found at www.bio-start.uk.
Share this article:
People also read
Book before March 29th to receive 20% discount*
Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....
Evonetix establishes scientific advisory board
CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution
Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...